NCT04401215: TARMAC

Technologically-Augmented Referrals to Mitigate Addiction Consequences

Completed NA Last updated 19 June 2020

What this trial tests

NA trial testing Technology Augmented Treatment for Screening, Brief Intervention, Referral, and Treatment (SBIRT) in Substance Use Disorders in 9 participants. Completed in 28 February 2020.

Timeline

23 September 2019

Primary endpoint
31 January 2020

28 February 2020

Quick facts

Lead sponsor	Washington State University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	screening
Enrollment	9
Start date	23 September 2019
Primary completion	31 January 2020
Estimated completion	28 February 2020
Sites	1 location across United States

Drugs / interventions tested

• Technology Augmented Treatment for Screening, Brief Intervention, Referral, and Treatment (SBIRT)

Conditions studied

• Substance Use Disorders — all drugs for Substance Use Disorders →

Sponsor

Washington State University

Who can join

21 and older, any sex, with Substance Use Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The implementation of screening and intervention for substance use disorders, such as Screening Brief Intervention Referral to Treatment (SBIRT), in the primary care setting has faced several challenges. In the past, physicians have cited barriers such as lack of time, lack of access to treatment, and lack of financial resources.

To overcome some of the barriers to screening and prevention of substance use disorders, many researchers have begun to explore novel approaches using web-based and mobile technology. While the quality of evidence is often inconsistent, there is promising research to show that interventions utilizing web-based or mobile technology for alcohol and other substance abuse can be effective. Features such as tailored feedback have shown to be more effective than similar programs without feedback, and interventions that combine self-administered therapy in conjunction with therapist-direction interventions show greater reductions in addictive behavior.

In this project, the investigators proposed to enhance the Screening Brief Intervention Referral to Treatment (SBIRT) with a digital tool that aims to save physician time and improve patient adherence to treatment goals, through extensive use of shared decision making, patient self-monitoring and goal tracking, and real-time tailored patient feedback and text follow-up for patients. Increase the screening and referral of those patients at risk for substance use disorder (SUD) thereby increasing the number of patients receiving higher level substance use treatment.

A total of 500 patients will be screened and randomized into two groups. 250 in the Technology Augmented Treatment group (intervention group) and 250 in the control group. The Washington State University research team, lead by Dr. McPherson, will screen and recruit subjects at CHAS Valley Clinic in Spokane, WA. Subjects in both groups will be followed up for 30 days.

At the initial study enrollment visit, the intervention group will be asked questions on an iPad about their eligibility. After the initial visit, subjects in the intervention group will receive up to 4 texts/day on his/her phone that will ask questions about their health after the visit.

The control group will be asked questions on an iPad and will be given a call 30 days after to ask questions about their health.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.